Key statistics
As of last trade Aurora Spine Corp (ASG:CVE) traded at 0.43, -8.51% below its 52-week high of 0.47, set on Oct 25, 2024.
52-week range
Open | 0.43 |
---|---|
High | 0.43 |
Low | 0.43 |
Bid | 0.43 |
Offer | 0.455 |
Previous close | 0.435 |
Average volume | 72.56k |
---|---|
Shares outstanding | 76.95m |
Free float | 56.86m |
P/E (TTM) | -- |
Market cap | 33.47m CAD |
EPS (TTM) | -0.0116 CAD |
Data delayed at least 15 minutes, as of Nov 14 2024 16:20 GMT.
More ▼
- Aurora Spine Corporation Schedules Conference Call to Update Investors and Discuss Third Quarter Fiscal Year 2024 Financial Results
- Aurora Spine Corporation Announces Release of its Hydra Osteo Onyx Lumbar System
- Aurora Spine Corporation Announces Participation at the North American Spine Society Annual Meeting
- Aurora Spine to Host ZOOM Call with Alpha Wolf Trading CEO Tim Weintraut
- Aurora Spine Corporation to Attend Latin America Pain Society (LAPS) Conference, Showcasing Innovations in Pain Management and Spine Care for Emerging Markets
- Aurora Spine Corporation to Attend Sixth Annual American Society of Pain & Neuroscience Conference
- Aurora Spine Corporation Schedules Conference Call to Update Investors and Discuss First Quarter Fiscal Year 2024 Financial Results
- Aurora Spine Corporation Celebrates Second Anniversary of Initial Implantation of the World’s First Bone Density Matched DEXA-C Cervical Interbody Fusion Device
- Aurora Spine’s Second Patent Related to DEXA Technology™ Patient-Matched Implant Technology Issued by the United States Patent Office
- The United States Patent Office Grants New Patent for Aurora Spine’s Translucent GhostTube™ Surgical Operating Tube
More ▼